Altimmune, Inc.
ALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326190
In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Altimmune, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 111 | 122 | +11 |
| Shares | 39.9M | 46.0M | +6.14M (+15.4%) |
| Value | $466.9M | $588.1M | +$121.2M (+26.0%) |
New holders (40)
Institutions that held Altimmune, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (29)
Institutions that held Altimmune, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.